img

Global Animal-derived Immune Globulin Products Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Animal-derived Immune Globulin Products Market Insights, Forecast to 2034

Immune globulin (Ig) short-term protection against hepatitis A and measles
Global Animal-derived Immune Globulin Products market is expected to reach to US$ 1303 million in 2024, with a positive growth of %, compared with US$ 1241 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Animal-derived Immune Globulin Products industry is evaluated to reach US$ 1726.3 million in 2029. The CAGR will be 4.8% during 2024 to 2029.
Globally, Animal-derived Immune Globulin Products key manufacturers include Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi and BTG Specialty Pharmaceuticals, etc. Pfizer, Rare Disease Therapeutics, Bioclon Institute are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Animal-derived Immune Globulin Products were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Animal-derived Immune Globulin Products market and estimated to attract more attentions from industry insiders and investors.
Animal-derived Immune Globulin Products can be divided into IVIg Liquid and IVIg Powder, etc. IVIg Liquid is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Animal-derived Immune Globulin Products is widely used in various fields, such as Immunodeficiency, Autoimmune Disease and Acute Infection,, etc. Immunodeficiency provides greatest supports to the Animal-derived Immune Globulin Products industry development. In 2022, global % sales of Animal-derived Immune Globulin Products went into Immunodeficiency filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Animal-derived Immune Globulin Products market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Animal-derived Immune Globulin Products market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Rare Disease Therapeutics
Bioclon Institute
Merck & Co
Sanofi
BTG Specialty Pharmaceuticals
Segment by Type
IVIg Liquid
IVIg Powder

Segment by Application


Immunodeficiency
Autoimmune Disease
Acute Infection

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Animal-derived Immune Globulin Products plant distribution, commercial date of Animal-derived Immune Globulin Products, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Animal-derived Immune Globulin Products introduction, etc. Animal-derived Immune Globulin Products Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Animal-derived Immune Globulin Products
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Animal-derived Immune Globulin Products Product Introduction
1.2 Market by Type
1.2.1 Global Animal-derived Immune Globulin Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market by Application
1.3.1 Global Animal-derived Immune Globulin Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Animal-derived Immune Globulin Products Sales Estimates and Forecasts 2018-2029
2.2 Global Animal-derived Immune Globulin Products Revenue by Region
2.2.1 Global Animal-derived Immune Globulin Products Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Animal-derived Immune Globulin Products Revenue by Region (2018-2024)
2.2.3 Global Animal-derived Immune Globulin Products Revenue by Region (2024-2029)
2.2.4 Global Animal-derived Immune Globulin Products Revenue Market Share by Region (2018-2029)
2.3 Global Animal-derived Immune Globulin Products Sales Estimates and Forecasts 2018-2029
2.4 Global Animal-derived Immune Globulin Products Sales by Region
2.4.1 Global Animal-derived Immune Globulin Products Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Animal-derived Immune Globulin Products Sales by Region (2018-2024)
2.4.3 Global Animal-derived Immune Globulin Products Sales by Region (2024-2029)
2.4.4 Global Animal-derived Immune Globulin Products Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Animal-derived Immune Globulin Products Sales by Manufacturers
3.1.1 Global Animal-derived Immune Globulin Products Sales by Manufacturers (2018-2024)
3.1.2 Global Animal-derived Immune Globulin Products Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Animal-derived Immune Globulin Products in 2022
3.2 Global Animal-derived Immune Globulin Products Revenue by Manufacturers
3.2.1 Global Animal-derived Immune Globulin Products Revenue by Manufacturers (2018-2024)
3.2.2 Global Animal-derived Immune Globulin Products Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Animal-derived Immune Globulin Products Revenue in 2022
3.3 Global Key Players of Animal-derived Immune Globulin Products, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Animal-derived Immune Globulin Products Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Animal-derived Immune Globulin Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Animal-derived Immune Globulin Products, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Animal-derived Immune Globulin Products, Product Offered and Application
3.8 Global Key Manufacturers of Animal-derived Immune Globulin Products, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Animal-derived Immune Globulin Products Sales by Type
4.1.1 Global Animal-derived Immune Globulin Products Historical Sales by Type (2018-2024)
4.1.2 Global Animal-derived Immune Globulin Products Forecasted Sales by Type (2024-2029)
4.1.3 Global Animal-derived Immune Globulin Products Sales Market Share by Type (2018-2029)
4.2 Global Animal-derived Immune Globulin Products Revenue by Type
4.2.1 Global Animal-derived Immune Globulin Products Historical Revenue by Type (2018-2024)
4.2.2 Global Animal-derived Immune Globulin Products Forecasted Revenue by Type (2024-2029)
4.2.3 Global Animal-derived Immune Globulin Products Revenue Market Share by Type (2018-2029)
4.3 Global Animal-derived Immune Globulin Products Price by Type
4.3.1 Global Animal-derived Immune Globulin Products Price by Type (2018-2024)
4.3.2 Global Animal-derived Immune Globulin Products Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Animal-derived Immune Globulin Products Sales by Application
5.1.1 Global Animal-derived Immune Globulin Products Historical Sales by Application (2018-2024)
5.1.2 Global Animal-derived Immune Globulin Products Forecasted Sales by Application (2024-2029)
5.1.3 Global Animal-derived Immune Globulin Products Sales Market Share by Application (2018-2029)
5.2 Global Animal-derived Immune Globulin Products Revenue by Application
5.2.1 Global Animal-derived Immune Globulin Products Historical Revenue by Application (2018-2024)
5.2.2 Global Animal-derived Immune Globulin Products Forecasted Revenue by Application (2024-2029)
5.2.3 Global Animal-derived Immune Globulin Products Revenue Market Share by Application (2018-2029)
5.3 Global Animal-derived Immune Globulin Products Price by Application
5.3.1 Global Animal-derived Immune Globulin Products Price by Application (2018-2024)
5.3.2 Global Animal-derived Immune Globulin Products Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Animal-derived Immune Globulin Products Market Size by Type
6.1.1 US & Canada Animal-derived Immune Globulin Products Sales by Type (2018-2029)
6.1.2 US & Canada Animal-derived Immune Globulin Products Revenue by Type (2018-2029)
6.2 US & Canada Animal-derived Immune Globulin Products Market Size by Application
6.2.1 US & Canada Animal-derived Immune Globulin Products Sales by Application (2018-2029)
6.2.2 US & Canada Animal-derived Immune Globulin Products Revenue by Application (2018-2029)
6.3 US & Canada Animal-derived Immune Globulin Products Market Size by Country
6.3.1 US & Canada Animal-derived Immune Globulin Products Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Animal-derived Immune Globulin Products Sales by Country (2018-2029)
6.3.3 US & Canada Animal-derived Immune Globulin Products Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Animal-derived Immune Globulin Products Market Size by Type
7.1.1 Europe Animal-derived Immune Globulin Products Sales by Type (2018-2029)
7.1.2 Europe Animal-derived Immune Globulin Products Revenue by Type (2018-2029)
7.2 Europe Animal-derived Immune Globulin Products Market Size by Application
7.2.1 Europe Animal-derived Immune Globulin Products Sales by Application (2018-2029)
7.2.2 Europe Animal-derived Immune Globulin Products Revenue by Application (2018-2029)
7.3 Europe Animal-derived Immune Globulin Products Market Size by Country
7.3.1 Europe Animal-derived Immune Globulin Products Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Animal-derived Immune Globulin Products Sales by Country (2018-2029)
7.3.3 Europe Animal-derived Immune Globulin Products Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Animal-derived Immune Globulin Products Market Size
8.1.1 China Animal-derived Immune Globulin Products Sales (2018-2029)
8.1.2 China Animal-derived Immune Globulin Products Revenue (2018-2029)
8.2 China Animal-derived Immune Globulin Products Market Size by Application
8.2.1 China Animal-derived Immune Globulin Products Sales by Application (2018-2029)
8.2.2 China Animal-derived Immune Globulin Products Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Animal-derived Immune Globulin Products Market Size by Type
9.1.1 Asia Animal-derived Immune Globulin Products Sales by Type (2018-2029)
9.1.2 Asia Animal-derived Immune Globulin Products Revenue by Type (2018-2029)
9.2 Asia Animal-derived Immune Globulin Products Market Size by Application
9.2.1 Asia Animal-derived Immune Globulin Products Sales by Application (2018-2029)
9.2.2 Asia Animal-derived Immune Globulin Products Revenue by Application (2018-2029)
9.3 Asia Animal-derived Immune Globulin Products Sales by Region
9.3.1 Asia Animal-derived Immune Globulin Products Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Animal-derived Immune Globulin Products Revenue by Region (2018-2029)
9.3.3 Asia Animal-derived Immune Globulin Products Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Market Size by Type
10.1.1 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Market Size by Application
10.2.1 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Country
10.3.1 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Rare Disease Therapeutics
11.2.1 Rare Disease Therapeutics Company Information
11.2.2 Rare Disease Therapeutics Overview
11.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Rare Disease Therapeutics Recent Developments
11.3 Bioclon Institute
11.3.1 Bioclon Institute Company Information
11.3.2 Bioclon Institute Overview
11.3.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bioclon Institute Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bioclon Institute Recent Developments
11.4 Merck & Co
11.4.1 Merck & Co Company Information
11.4.2 Merck & Co Overview
11.4.3 Merck & Co Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Merck & Co Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck & Co Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Sanofi Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 BTG Specialty Pharmaceuticals
11.6.1 BTG Specialty Pharmaceuticals Company Information
11.6.2 BTG Specialty Pharmaceuticals Overview
11.6.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BTG Specialty Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Animal-derived Immune Globulin Products Industry Chain Analysis
12.2 Animal-derived Immune Globulin Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Animal-derived Immune Globulin Products Production Mode & Process
12.4 Animal-derived Immune Globulin Products Sales and Marketing
12.4.1 Animal-derived Immune Globulin Products Sales Channels
12.4.2 Animal-derived Immune Globulin Products Distributors
12.5 Animal-derived Immune Globulin Products Customers
13 Market Dynamics
13.1 Animal-derived Immune Globulin Products Industry Trends
13.2 Animal-derived Immune Globulin Products Market Drivers
13.3 Animal-derived Immune Globulin Products Market Challenges
13.4 Animal-derived Immune Globulin Products Market Restraints
14 Key Findings in The Global Animal-derived Immune Globulin Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal-derived Immune Globulin Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of IVIg Liquid
Table 3. Major Manufacturers of IVIg Powder
Table 4. Global Animal-derived Immune Globulin Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Animal-derived Immune Globulin Products Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Animal-derived Immune Globulin Products Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Animal-derived Immune Globulin Products Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Animal-derived Immune Globulin Products Revenue Market Share by Region (2018-2024)
Table 9. Global Animal-derived Immune Globulin Products Revenue Market Share by Region (2024-2029)
Table 10. Global Animal-derived Immune Globulin Products Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Animal-derived Immune Globulin Products Sales by Region (2018-2024) & (K Units)
Table 12. Global Animal-derived Immune Globulin Products Sales by Region (2024-2029) & (K Units)
Table 13. Global Animal-derived Immune Globulin Products Sales Market Share by Region (2018-2024)
Table 14. Global Animal-derived Immune Globulin Products Sales Market Share by Region (2024-2029)
Table 15. Global Animal-derived Immune Globulin Products Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Animal-derived Immune Globulin Products Sales Share by Manufacturers (2018-2024)
Table 17. Global Animal-derived Immune Globulin Products Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Animal-derived Immune Globulin Products Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Animal-derived Immune Globulin Products, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Animal-derived Immune Globulin Products Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Animal-derived Immune Globulin Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Animal-derived Immune Globulin Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal-derived Immune Globulin Products as of 2022)
Table 23. Global Key Manufacturers of Animal-derived Immune Globulin Products, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Animal-derived Immune Globulin Products, Product Offered and Application
Table 25. Global Key Manufacturers of Animal-derived Immune Globulin Products, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Animal-derived Immune Globulin Products Sales by Type (2018-2024) & (K Units)
Table 28. Global Animal-derived Immune Globulin Products Sales by Type (2024-2029) & (K Units)
Table 29. Global Animal-derived Immune Globulin Products Sales Share by Type (2018-2024)
Table 30. Global Animal-derived Immune Globulin Products Sales Share by Type (2024-2029)
Table 31. Global Animal-derived Immune Globulin Products Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Animal-derived Immune Globulin Products Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Animal-derived Immune Globulin Products Revenue Share by Type (2018-2024)
Table 34. Global Animal-derived Immune Globulin Products Revenue Share by Type (2024-2029)
Table 35. Animal-derived Immune Globulin Products Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Animal-derived Immune Globulin Products Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Animal-derived Immune Globulin Products Sales by Application (2018-2024) & (K Units)
Table 38. Global Animal-derived Immune Globulin Products Sales by Application (2024-2029) & (K Units)
Table 39. Global Animal-derived Immune Globulin Products Sales Share by Application (2018-2024)
Table 40. Global Animal-derived Immune Globulin Products Sales Share by Application (2024-2029)
Table 41. Global Animal-derived Immune Globulin Products Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Animal-derived Immune Globulin Products Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Animal-derived Immune Globulin Products Revenue Share by Application (2018-2024)
Table 44. Global Animal-derived Immune Globulin Products Revenue Share by Application (2024-2029)
Table 45. Animal-derived Immune Globulin Products Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Animal-derived Immune Globulin Products Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Animal-derived Immune Globulin Products Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Animal-derived Immune Globulin Products Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Animal-derived Immune Globulin Products Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Animal-derived Immune Globulin Products Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Animal-derived Immune Globulin Products Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Animal-derived Immune Globulin Products Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Animal-derived Immune Globulin Products Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Animal-derived Immune Globulin Products Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Animal-derived Immune Globulin Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Animal-derived Immune Globulin Products Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Animal-derived Immune Globulin Products Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Animal-derived Immune Globulin Products Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Animal-derived Immune Globulin Products Sales by Country (2024-2029) & (K Units)
Table 60. Europe Animal-derived Immune Globulin Products Sales by Type (2018-2024) & (K Units)
Table 61. Europe Animal-derived Immune Globulin Products Sales by Type (2024-2029) & (K Units)
Table 62. Europe Animal-derived Immune Globulin Products Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Animal-derived Immune Globulin Products Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Animal-derived Immune Globulin Products Sales by Application (2018-2024) & (K Units)
Table 65. Europe Animal-derived Immune Globulin Products Sales by Application (2024-2029) & (K Units)
Table 66. Europe Animal-derived Immune Globulin Products Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Animal-derived Immune Globulin Products Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Animal-derived Immune Globulin Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Animal-derived Immune Globulin Products Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Animal-derived Immune Globulin Products Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Animal-derived Immune Globulin Products Sales by Country (2018-2024) & (K Units)
Table 72. Europe Animal-derived Immune Globulin Products Sales by Country (2024-2029) & (K Units)
Table 73. China Animal-derived Immune Globulin Products Sales by Type (2018-2024) & (K Units)
Table 74. China Animal-derived Immune Globulin Products Sales by Type (2024-2029) & (K Units)
Table 75. China Animal-derived Immune Globulin Products Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Animal-derived Immune Globulin Products Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Animal-derived Immune Globulin Products Sales by Application (2018-2024) & (K Units)
Table 78. China Animal-derived Immune Globulin Products Sales by Application (2024-2029) & (K Units)
Table 79. China Animal-derived Immune Globulin Products Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Animal-derived Immune Globulin Products Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Animal-derived Immune Globulin Products Sales by Type (2018-2024) & (K Units)
Table 82. Asia Animal-derived Immune Globulin Products Sales by Type (2024-2029) & (K Units)
Table 83. Asia Animal-derived Immune Globulin Products Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Animal-derived Immune Globulin Products Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Animal-derived Immune Globulin Products Sales by Application (2018-2024) & (K Units)
Table 86. Asia Animal-derived Immune Globulin Products Sales by Application (2024-2029) & (K Units)
Table 87. Asia Animal-derived Immune Globulin Products Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Animal-derived Immune Globulin Products Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Animal-derived Immune Globulin Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Animal-derived Immune Globulin Products Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Animal-derived Immune Globulin Products Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Animal-derived Immune Globulin Products Sales by Region (2018-2024) & (K Units)
Table 93. Asia Animal-derived Immune Globulin Products Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales by Country (2024-2029) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Rare Disease Therapeutics Company Information
Table 113. Rare Disease Therapeutics Description and Major Businesses
Table 114. Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Rare Disease Therapeutics Recent Developments
Table 117. Bioclon Institute Company Information
Table 118. Bioclon Institute Description and Major Businesses
Table 119. Bioclon Institute Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Bioclon Institute Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bioclon Institute Recent Developments
Table 122. Merck & Co Company Information
Table 123. Merck & Co Description and Major Businesses
Table 124. Merck & Co Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Merck & Co Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Merck & Co Recent Developments
Table 127. Sanofi Company Information
Table 128. Sanofi Description and Major Businesses
Table 129. Sanofi Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Sanofi Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Sanofi Recent Developments
Table 132. BTG Specialty Pharmaceuticals Company Information
Table 133. BTG Specialty Pharmaceuticals Description and Major Businesses
Table 134. BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. BTG Specialty Pharmaceuticals Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Animal-derived Immune Globulin Products Distributors List
Table 140. Animal-derived Immune Globulin Products Customers List
Table 141. Animal-derived Immune Globulin Products Market Trends
Table 142. Animal-derived Immune Globulin Products Market Drivers
Table 143. Animal-derived Immune Globulin Products Market Challenges
Table 144. Animal-derived Immune Globulin Products Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal-derived Immune Globulin Products Product Picture
Figure 2. Global Animal-derived Immune Globulin Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Animal-derived Immune Globulin Products Market Share by Type in 2022 & 2029
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Animal-derived Immune Globulin Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Animal-derived Immune Globulin Products Market Share by Application in 2022 & 2029
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Animal-derived Immune Globulin Products Report Years Considered
Figure 12. Global Animal-derived Immune Globulin Products Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Animal-derived Immune Globulin Products Revenue 2018-2029 (US$ Million)
Figure 14. Global Animal-derived Immune Globulin Products Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Animal-derived Immune Globulin Products Revenue Market Share by Region (2018-2029)
Figure 16. Global Animal-derived Immune Globulin Products Sales 2018-2029 ((K Units)
Figure 17. Global Animal-derived Immune Globulin Products Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Animal-derived Immune Globulin Products Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Animal-derived Immune Globulin Products Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Animal-derived Immune Globulin Products Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Animal-derived Immune Globulin Products Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Animal-derived Immune Globulin Products Sales YoY (2018-2029) & (K Units)
Figure 23. China Animal-derived Immune Globulin Products Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Animal-derived Immune Globulin Products Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Animal-derived Immune Globulin Products Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Animal-derived Immune Globulin Products Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Animal-derived Immune Globulin Products in the World: Market Share by Animal-derived Immune Globulin Products Revenue in 2022
Figure 30. Global Animal-derived Immune Globulin Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Animal-derived Immune Globulin Products Sales Market Share by Type (2018-2029)
Figure 32. Global Animal-derived Immune Globulin Products Revenue Market Share by Type (2018-2029)
Figure 33. Global Animal-derived Immune Globulin Products Sales Market Share by Application (2018-2029)
Figure 34. Global Animal-derived Immune Globulin Products Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Animal-derived Immune Globulin Products Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Animal-derived Immune Globulin Products Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Animal-derived Immune Globulin Products Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Animal-derived Immune Globulin Products Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Animal-derived Immune Globulin Products Revenue Share by Country (2018-2029)
Figure 40. US & Canada Animal-derived Immune Globulin Products Sales Share by Country (2018-2029)
Figure 41. U.S. Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Animal-derived Immune Globulin Products Sales Market Share by Type (2018-2029)
Figure 44. Europe Animal-derived Immune Globulin Products Revenue Market Share by Type (2018-2029)
Figure 45. Europe Animal-derived Immune Globulin Products Sales Market Share by Application (2018-2029)
Figure 46. Europe Animal-derived Immune Globulin Products Revenue Market Share by Application (2018-2029)
Figure 47. Europe Animal-derived Immune Globulin Products Revenue Share by Country (2018-2029)
Figure 48. Europe Animal-derived Immune Globulin Products Sales Share by Country (2018-2029)
Figure 49. Germany Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 50. France Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 51. UK Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 54. China Animal-derived Immune Globulin Products Sales Market Share by Type (2018-2029)
Figure 55. China Animal-derived Immune Globulin Products Revenue Market Share by Type (2018-2029)
Figure 56. China Animal-derived Immune Globulin Products Sales Market Share by Application (2018-2029)
Figure 57. China Animal-derived Immune Globulin Products Revenue Market Share by Application (2018-2029)
Figure 58. Asia Animal-derived Immune Globulin Products Sales Market Share by Type (2018-2029)
Figure 59. Asia Animal-derived Immune Globulin Products Revenue Market Share by Type (2018-2029)
Figure 60. Asia Animal-derived Immune Globulin Products Sales Market Share by Application (2018-2029)
Figure 61. Asia Animal-derived Immune Globulin Products Revenue Market Share by Application (2018-2029)
Figure 62. Asia Animal-derived Immune Globulin Products Revenue Share by Region (2018-2029)
Figure 63. Asia Animal-derived Immune Globulin Products Sales Share by Region (2018-2029)
Figure 64. Japan Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 68. India Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Animal-derived Immune Globulin Products Sales Share by Country (2018-2029)
Figure 75. Brazil Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Animal-derived Immune Globulin Products Revenue (2018-2029) & (US$ Million)
Figure 80. Animal-derived Immune Globulin Products Value Chain
Figure 81. Animal-derived Immune Globulin Products Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed